About
Synendos Therapeutics is a clinical-stage neuroscience company developing therapies targeting the Endocannabinoid System to treat neuropsychiatric disorders such as Generalized Anxiety Disorder and Post-Traumatic Stress Disorder.
Explore Synendos Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.